Tag Archives: FDA

In Search Of Novelty: 2017’s New FDA Drug Approvals
November 30, 2017

It’s been an exciting year for new drug approvals, with the FDA on a similar pace to the gangbuster year of 2015. Many of these new medicines address significant and meaningful needs, or offer additional therapeutic choices for patients and

Leave a comment